User profiles for Raphael Le Mao

raphael le mao

MD
Verified email at chu-brest.fr
Cited by 1160

Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis

…, P Rali, A Muriel, B Bikdeli, P Ruiz-Artacho, R Le Mao… - Chest, 2021 - Elsevier
Background Individual studies have reported widely variable rates for VTE and bleeding
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …

Venous thromboembolism associated with assisted reproductive technology: a systematic review and meta-analysis

…, C Tremouilhac, P Merviel, R Le Mao… - Thrombosis and …, 2023 - thieme-connect.com
Background Hormonal exposure leads to an increased risk of venous thromboembolism (VTE)
but the risk of VTE associated with assisted reproductive technology (ART) is not clearly …

Rivaroxaban vs dalteparin in cancer-associated thromboembolism: a randomized trial

…, G Poénou, B Imbert, N Zenati, E Le Moigne, R Le Mao… - Chest, 2022 - Elsevier
Le Moigne, Aurélien Delluc, Raphael Le Mao, and Clément Hoffmann): 10 patients; CH de
Toulon (Antoine Elias and Marie Elias): 10 patients; CHU de Dijon (Nicolas Falvo, Romaric …

Prevalence of pulmonary embolism among patients with COPD hospitalized with acutely worsening respiratory symptoms

F Couturaud, L Bertoletti, J Pastre, PM Roy, R Le Mao… - Jama, 2021 - jamanetwork.com
Importance The prevalence of pulmonary embolism in patients with chronic obstructive
pulmonary disease (COPD) and acutely worsening respiratory symptoms remains uncertain. …

[HTML][HTML] Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism …

…, S Soudet, R Le Mao, F Maurier, V Le Moing… - …, 2023 - thelancet.com
Background Venous thromboembolism is a major complication of coronavirus disease 2019
(COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation …

[HTML][HTML] Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French …

…, E Guérot, R Larcher, S Ricome, R Le Mao… - Annals of Intensive …, 2018 - Springer
Background Anti-synthetase (AS) and dermato-pulmonary associated with anti-MDA-5
antibodies (aMDA-5) syndromes are near one of the other autoimmune inflammatory myopathies …

Patent foramen ovale and ischemic stroke in patients with pulmonary embolism: a prospective cohort study

…, R Didier, Y Jobic, N Paleiron, R Le Mao… - Annals of internal …, 2019 - acpjournals.org
Background: Pulmonary embolism (PE) is associated with increased risk for ischemic stroke,
but the underlying mechanism remains unclear. The authors hypothesized that paradoxical …

Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: the BACS score

…, T Morimoto, T Kimura, R Le Mao… - European …, 2020 - Eur Respiratory Soc
Background Improved prediction of the risk of major bleeding in patients with acute pulmonary
embolism (PE) receiving systemic thrombolysis is crucial to guide the choice of therapy. …

[HTML][HTML] Early heart rate variability evaluation enables to predict ICU patients' outcome

L Bodenes, QT N'Guyen, R Le Mao, N Ferrière… - Scientific Reports, 2022 - nature.com
Raphaël Le Mao … Dr Le mao declares he has no conflict of interest related to this
research. Dr Ferriere declares he has no conflict of interest related to this research. Pr. …

Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies

…, G Le Gal, N Paleiron, R Le Mao… - … of Thrombosis and …, 2022 - Wiley Online Library
Raphael Le MaoRaphael Le MaoLe Mao declares he has no conflict of interest related
to this research. Dr. Pernod declares he has no conflict of interest related to this research. …